These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 48962)

  • 21. Functional evaluation of T-lymphocytes from peripheral blood and spleens in Hodgkin's disease.
    Mukhopadhyaya R; Advani SH; Gangal SG
    Br J Cancer; 1987 Dec; 56(6):800-2. PubMed ID: 2829954
    [No Abstract]   [Full Text] [Related]  

  • 22. [Hodgkin's disease: effect of spenectomy on the immune status (author's transl)].
    Diehl V; Schaadt M; Kalden RJ; Hagedorn C; Schmidt N; Deinhardt J
    Klin Wochenschr; 1978 Aug; 56(16):809-18. PubMed ID: 211317
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Letter: IgM receptors on cells in Hodgkin's disease.
    Habeshaw JA; Stuart AE; Dewar AE; Young G
    Lancet; 1976 Apr; 1(7965):916. PubMed ID: 58187
    [No Abstract]   [Full Text] [Related]  

  • 24. [Ratio of T and B lymphocytes in spleens of patients with malignant granulomatosis].
    Płzańska A; Szadowska A; Robak T; Kabza R; Mazurowa A; Woźniak L; Kałuzna W
    Pol Arch Med Wewn; 1978 Nov; 60(5):405-12. PubMed ID: 364442
    [No Abstract]   [Full Text] [Related]  

  • 25. In vitro characterization of T and B lymphocytes in chronic lymphatic leukemia and Hodgkin's disease.
    Tursi A; Ferrannini A; Losito G
    Boll Ist Sieroter Milan; 1974; 53(1):suppl:306. PubMed ID: 4604590
    [No Abstract]   [Full Text] [Related]  

  • 26. T and B blocking factors in Hodgkin's disease.
    Bentwich R; Cohen R; Brautbar C
    Adv Exp Med Biol; 1976; 66():685-90. PubMed ID: 1083664
    [No Abstract]   [Full Text] [Related]  

  • 27. [Effect of cytotoxic Hodgkin's serum on LIF activity of T- and B-lymphocytes].
    Chisesi T; Giacobbo M; Capnist T
    Boll Ist Sieroter Milan; 1978 Sep; 57(4):428-33. PubMed ID: 310684
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunodeficiencies in Hodgkin's Disease. Part II: B cell immunity, complement systems and phagocytic cell systems.
    Gupta S
    Clin Bull; 1981; 11(3):110-9. PubMed ID: 7039866
    [No Abstract]   [Full Text] [Related]  

  • 29. [Comparative studies of the proportions of T, B and O-lymphocytes and of the degree of blastic transformation following stimulation with PHA in patients with Hodgkin's disease].
    Pluzańska A
    Pol Arch Med Wewn; 1977 Apr; 57(4):297-305. PubMed ID: 300871
    [No Abstract]   [Full Text] [Related]  

  • 30. Lymphocyte surface immunoglobulins in Hodgkin's disease.
    Gergely P; Szegedi G; Berényi E; Petrányi G
    N Engl J Med; 1973 Jul; 289(4):220. PubMed ID: 4576536
    [No Abstract]   [Full Text] [Related]  

  • 31. Proceedings: T and B blocking factors in Hodgkin's disease.
    Bentwich Z; Cohen R; Brautbar C
    Isr J Med Sci; 1975 Dec; 11(12):1382. PubMed ID: 1082876
    [No Abstract]   [Full Text] [Related]  

  • 32. Spontaneous and Concanavalin A-induced suppressor activity in control and Hodgkin's disease patients.
    Akbar AN; Jones DB; Wright DH
    Br J Cancer; 1984 Mar; 49(3):349-56. PubMed ID: 6231045
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Letter: The spleen in Hodgkin's disease.
    Halie MR; Eibergen R; van der Broek AA; Nieweg HO
    Lancet; 1974 Nov; 2(7888):1078. PubMed ID: 4138410
    [No Abstract]   [Full Text] [Related]  

  • 34. [The character and function of mononuclear cells in the spleen and peripheral blood in Hodgkin's disease].
    Pick AI; Loven D; Douer D; Kessler H; Weiss H; Duczyminer M; Har-Zahav L
    Harefuah; 1980; 98(10):433-7. PubMed ID: 7005036
    [No Abstract]   [Full Text] [Related]  

  • 35. Hodgkin's disease in children: investigation of T and B lymphocytes.
    Ilyin NV; Kolygin BA; Letsky VB; Fedoreev GA; Zubzhitsky YN
    Neoplasma; 1978; 25(1):75-81. PubMed ID: 305545
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Peripheral blood T- and B-lymphocyte number in Hodgkin's disease].
    Dziewulska-Bokiniec A; Sztaba-Kania M
    Nowotwory; 1980; 30(2):155-9. PubMed ID: 6968060
    [No Abstract]   [Full Text] [Related]  

  • 37. Nodular lymphocyte predominance type of Hodgkin's disease is a germinal center lymphoma.
    Timens W; Visser L; Poppema S
    Lab Invest; 1986 Apr; 54(4):457-61. PubMed ID: 3083157
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anti-lymphocytic globulin in Hodgkin's disease.
    Jones DB; Payne SV; Wright DH
    Biomedicine; 1977 Jul; 27(5):177-8. PubMed ID: 303527
    [No Abstract]   [Full Text] [Related]  

  • 39. Antibody-dependent lymphocytotoxicity induced by immunoglobulin G from Hodgkin's disease splenic lymphocytes.
    Longmire RL; Ryan S; McMillan R; Lightsey A; Heath V
    Science; 1978 Jan; 199(4324):71-2. PubMed ID: 17569485
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Immunity and hypersensitivity in Hodgkin's lymphoma].
    Leoni P; Marchegiani G; Montillo M; Centurioni R; Montroni M; Danieli G
    Minerva Med; 1982 May; 73(20):1361-9. PubMed ID: 6210855
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.